Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Brain Disorders

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Brain Disorders in 1 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonald, JW1
Roeser, NF1
Silverstein, FS1
Johnston, MV1

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Brain Disorders

ArticleYear
Quantitative assessment of neuroprotection against NMDA-induced brain injury.
    Experimental neurology, 1989, Volume: 106, Issue:3

    Topics: Animals; Aspartic Acid; Brain; Brain Diseases; Choline O-Acetyltransferase; Corpus Striatum; Dibenzo

1989